Effective Lenvatinib Treatment Complicated with Secondary Tracheocutaneous Fistula in Patients with Advanced Anaplastic Thyroid Carcinoma

被引：1
|
作者：
Wu, Wen-Chi [1 ]
Lai, Jiun-, I [2 ,3 ]
Chen, Jui-Yu [4 ]
Liu, Chun-Yu [2 ,3 ,5 ]
机构：
[1] Taipei Vet Gen Hosp, Dept Med, Taipei 11217, Taiwan
[2] Natl Yang Ming Univ, Inst Clin Med, Taipei 11221, Taiwan
[3] Taipei Vet Gen Hosp, Dept Oncol, Div Med Oncol, Taipei 11217, Taiwan
[4] Taipei Vet Gen Hosp, Dept Surg, Taipei 11217, Taiwan
[5] Taipei Vet Gen Hosp, Div Transfus Med, Dept Med, Taipei 11217, Taiwan
来源：
REPORTS | 2019年 / 2卷 / 03期
关键词：
lenvatinib; anaplastic thyroid carcinoma (ATC); tracheocutaneous fistula; tumor-cutaneous fistula; carotid blowout syndrome;
D O I：
10.3390/reports2030022
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Anaplastic thyroid carcinoma (ATC) is a fatal disease with a poor prognosis. Lenvatinib is an oral multi-targeted tyrosine kinase inhibitor (TKI) which is approved in Japan for the treatment of ATC. Data of treatment response and adverse effects of lenvatinib in ATC patients is still relatively scarce, especially in non-Japanese patient populations. Here we report dramatic treatment effects of lenvatinib in two patients with stage IVc ATC, who later developed significant morbidities including tracheal perforation and fistula formation. Our cases demonstrate the efficacy and provide cautionary information for treatment of ATC. In treating advanced ATC patients with lenvatinib, close monitoring is highly recommended.
引用
收藏
页数：6
相关论文
共 50 条
  • [1] Combination of Lenvatinib and Pembrolizumab Is an Effective Treatment Option for Anaplastic and Poorly Differentiated Thyroid Carcinoma
    Dierks, Christine
    Seufert, Jochen
    Aumann, Konrad
    Ruf, Juri
    Klein, Claudius
    Kiefer, Selina
    Rassner, Michael
    Boerries, Melanie
    Zielke, Andreas
    la Rosee, Paul
    Meyer, Philipp Tobias
    Kroiss, Matthias
    Weissenberger, Christian
    Schumacher, Tilmann
    Metzger, Patrick
    Weiss, Harald
    Smaxwil, Constantin
    Laubner, Katharina
    Duyster, Justus
    von Bubnoff, Nikolas
    Miething, Cornelius
    Thomusch, Oliver
    THYROID, 2021, 31 (07) : 1076 - 1085
  • [2] Anaplastic thyroid carcinoma diagnosed after treatment of lenvatinib for papillary thyroid carcinoma
    Yamazaki, Haruhiko
    Iwasaki, Hiroyuki
    Suganuma, Nobuyasu
    Toda, Soji
    Masudo, Katsuhiko
    Nakayama, Hirotaka
    Rino, Yasushi
    Masuda, Munetaka
    ENDOCRINOLOGY DIABETES AND METABOLISM CASE REPORTS, 2019,
  • [3] Lenvatinib and pembrolizumab as save and effective combination treatment in 8 patients with metastasized anaplastic (ATC) or poorly differentiated thyroid carcinoma (PDTC)
    Dierks, C.
    Miething, C.
    Thomusch, O.
    von Bubnoff, N.
    Duyster, J.
    ANNALS OF ONCOLOGY, 2018, 29
  • [4] Conversion surgery after lenvatinib treatment for anaplastic thyroid carcinoma: a case report
    Haruhiko Yamazaki
    Katsuhiko Masudo
    Sachie Kanada
    Yoshiaki Inayama
    Hiroyuki Hayashi
    Yu Fujii
    Yasushi Rino
    Surgical Case Reports, 9
  • [5] Conversion surgery after lenvatinib treatment for anaplastic thyroid carcinoma: a case report
    Yamazaki, Haruhiko
    Masudo, Katsuhiko
    Kanada, Sachie
    Inayama, Yoshiaki
    Hayashi, Hiroyuki
    Fujii, Yu
    Rino, Yasushi
    SURGICAL CASE REPORTS, 2023, 9 (01)
  • [6] Real-world experience of lenvatinib in patients with advanced anaplastic thyroid cancer
    Mijin Kim
    Jonghwa Ahn
    Dong Eun Song
    Jee Hee Yoon
    Ho-Cheol Kang
    Dong Jun Lim
    Won Gu Kim
    Tae Yong Kim
    Won Bae Kim
    Young Kee Shong
    Min Ji Jeon
    Bo Hyun Kim
    Endocrine, 2021, 71 : 427 - 433
  • [7] Real-world experience of lenvatinib in patients with advanced anaplastic thyroid cancer
    Kim, Mijin
    Ahn, Jonghwa
    Song, Dong Eun
    Yoon, Jee Hee
    Kang, Ho-Cheol
    Lim, Dong Jun
    Kim, Won Gu
    Kim, Tae Yong
    Kim, Won Bae
    Shong, Young Kee
    Jeon, Min Ji
    Kim, Bo Hyun
    ENDOCRINE, 2021, 71 (02) : 427 - 433
  • [8] Three Cases of Anaplastic Thyroid Carcinoma Transformation and Leukocytosis during Lenvatinib Treatment
    Iwasaki, Hiroyuki
    Toda, Soji
    Murayama, Daisuke
    Takahashi, Hiroyuki
    CASE REPORTS IN ENDOCRINOLOGY, 2020, 2020
  • [9] Lenvatinib Administration for Anaplastic Thyroid Carcinoma with Brain Metastasis
    Obayashi, Atsuto
    Aoki, Kazuma
    Wada, Tadayoshi
    Furuie, Hiromi
    Kuraoka, Kazuya
    Hamamoto, Takao
    Tatsukawa, Takaharu
    ACTA MEDICA OKAYAMA, 2023, 77 (02) : 227 - 232
  • [10] Outcome of initial lenvatinib treatment in patients with unresectable anaplastic thyroid cancer
    Iwasaki, Hiroyuki
    Toda, Soji
    Takahashi, Akari
    Masudo, Katsuhiko
    ONCOLOGY LETTERS, 2023, 26 (03)
12345